A NEW HOPE FOR WEIGHT REGULATION?

Researchers are increasingly focused on retatrutide, a innovative treatment developed by Eli Lilly, as a possible step in physique loss . Unlike many earlier approaches, retatrutide is a double -action compound targeting both GLP-1 and GIP, chemicals that impact appetite and blood sugar control .